youtube_live
Q2 2026 earnings • released • Revenue beat +0.39%
See resultschevron_right
4519:TYO
Chugai Pharmaceutical Co Ltd
¥6,999.00
arrow_upward
+2.21%(+151.00) 1D
Jul 28, 3:30:00 PM GMT+9 · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4519...
Open
¥6,958
High
¥7,149
Low
¥6,941
Mkt. cap
11.75T
Avg. vol.
2.42M
Volume
4.14M
Dividend
1.74%
Quarterly dividend
¥30
Ex-dividend date
Jun 29, 2026
P/E ratio
25.47
52-wk high
¥10,700
52-wk low
¥5,942
EPS
¥275
Shares outstanding
547.19M
No. of employees
5K
Open
¥6,958
High
¥7,149
Low
¥6,941
Mkt. cap
11.75T
Avg. vol.
2.42M
Volume
4.14M
Dividend
1.74%
Quarterly dividend
¥30
Ex-dividend date
Jun 29, 2026
P/E ratio
25.47
52-wk high
¥10,700
52-wk low
¥5,942
EPS
¥275
Shares outstanding
547.19M
No. of employees
5K
News stories
From sources across the web
finance.biggo.com
·
1 day ago
[4519.T FY2026 Q2 Earnings Call] Chugai Pharmaceutical Q2 Core Operating Profit Rises 21% to ¥329.1 Billion as Overseas Blockbusters and New Drug Royalties Diversify Revenue Structure
TipRanks
·
3 days ago
Chugai Pharmaceutical Earnings Call Highlights Growth Momentum
TradingView
·
3 days ago
Chugai Pharmaceutical : Revenue and profit surged, with strong sales, record filings, and continued investment in innovation
www.marketscreener.com
·
4 days ago
Chugai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp
AI content may include mistakes. Learn more